AstraZeneca announced that it has successfully completed the European Union Mutual Recognition Procedure (MRP) for Symbicort? Maintenance And Reliever Therapy (Symbicort SMART?). This new asthma treatment approach allows patients to use just one inhaler for both maintenance and relief of asthma symptoms.
UCB (Euronext Brussels: UCB) and Biogen Idec (NASDAQ: BIIB) today announced a global collaboration to jointly develop and commercialize CDP323 for the treatment of relapsing-remitting multiple sclerosis (MS) and other potential indications. CDP323 is an orally active small molecule alpha4-integrin inhibitor expected to enter Phase II clinical trials next year.
Blackwell Publishing is set to break into an exciting new area of clinical psychiatry with its new journal – Early Intervention in Psychiatry. The journal will be launched at the IEPA Conference in Birmingham in October 2006, and will publish its inaugural issue in February 2007.
Researchers will report results of a follow-on study of the first non-invasive, diabetes-screening device that was able to significantly outperform the fasting plasma glucose (FPG) test and the A1C test for identifying diabetes and pre-diabetes in individuals with one or more known risk factors for the disease. Presented at the 2006 Scientific Assembly of the American Academy of Family Physicians, held here, the study showed a prototype of the device was able to identify 29% more patients than the FPG test and 17% more patients than the A1C test. Both the FPG and A1C are blood tests used to screen and evaluate patients at risk for diabetes.
Johnson & Johnson Pharmaceutical Research and Development, L.L.C. today announced that ceftobiprole, a novel cephalosporin(1) antibiotic in Phase III clinical trials, was found to be active against complicated skin infections caused by common, potentially deadly bacteria, including MRSA. These data were from two poster presentations given at the 46th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). These data also were highlighted by ICAAC. Ceftobiprole is being co-developed with Basilea Pharmaceutica, Ltd. through an exclusive worldwide collaboration.
Pfizer Inc said today that the European Commission has approved Champix(R) (varenicline), a novel pill for smoking cessation in adults. In addition, because smokers often need considerable support to quit successfully, Champix will be available with a patient support plan which smokers can customize to address their individual behavioral triggers as they try to quit smoking.
Study Finds No Increased Risk of Lymphoma or Tumors Associated with Anti-TNF Therapy Over Methotrexate Use Among Rheumatoid Arthritis Patients. Patients with rheumatoid arthritis (RA), an autoimmune, inflammatory disease marked by progressive joint and organ damage, face a high risk of developing cancer.
Massage is probably the oldest and simplest existing form of medical care that it has been applied for relaxation, fitness, and other health purposes. Basically, massage therapy is a therapeutic technique that involves manipulation of the soft tissues of the body. It is the calming, therapeutic process of kneading, stroking, and pressing the different areas of the body to alleviate pain, relieve stress and tensions, or relax, stimulate and tone the body.
Women who are worried about the extra fat on their figure but are too busy to exercise, are now being offered an easy way out when it comes to losing weight by clinics in the UK who are offering them a one hour ?walk in, walk out? liposuction treatment during their lunch break.
The article lists some simple, informative tips that will help you have a better experience with arthritis. If you’ve been thinking you need to know more about it, here’s your opportunity.